Individual Study / CoV2IP

Assessing the impact of the current SARS-CoV-2 vaccine in Indigenous populations in Arctic Canada
  1. Home
  2. Individual Studies
  3. CoV2IP

Assessing the impact of the current SARS-CoV-2 vaccine in Indigenous populations in Arctic Canada

Networks -
Datasets -
Variables -
Start Year
2021
End Year
2023
Visit CoV2IP
Add to cart

Members

Download
Investigators Contacts
  • Rachel Oystrek
    Government of Northwest Territories
  • Dr AnneMarie Pegg
  • Dr Karen Doucette
    University of Alberta
  • Dr Adrian Wagg
    University of Alberta
  • Dr Carolyn Gotay
    University of British Columbia
  • Dr Kami Kandola
    Office of the Chief Public Health Officer
  • Dr Stephanie Irlbacher-Fox
    University of Carleton
  • Dr Fariba Kolahdooz
    University of Alberta
  • Dr Sangita Sharma
    University of Alberta
  • Dr Sangita Sharma
    University of Alberta

Design

Study design
Cross-sectional
Follow Up
The questionnaire will be repeated annually in the same participating communities.
Supplementary Information
The communities and Community Advisory Board have approved the protocols, methods, and questionnaires.

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
124
Number of Participants with Biological Samples

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other
Yes
No
Not applicable
Don't know

Timeline

CoV2IP-Individuals

Selection Criteria
Minimum age
18
Newborns
Twins
Countries
  • Canada
Territory
Ethnic Origin
  • Indigenous
Health Status
Other Criteria
Must have lived in respective community for the past two months (at time of data collection)

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Other specific population : Indigenous (self-identifying)
Supplementary Information
Participants were recruited with the help of Local Community Research Assistants (RAs) calling community members and organizations through word of mouth and social media posts shared by the local RAs and organizations.

Number of Participants

Number of Participants
124
Number of Participants with Biological Samples
Data Collection Events
# Name Description Start End
0 CoV2IP-Individuals-Year1 Impact of medium- and long-term side effects of SARS-CoV-2 vaccine were assessed through questionnaires. 2021-07 2021-11
1 CoV2IP-Individuals-Year2 Impact of medium- and long-term side effects of SARS-CoV-2 vaccine were assessed through questionnaires. 2022-08 2022-12
2 CoV2IP-Individuals-Year3 Impact of medium- and long-term side effects of SARS-CoV-2 vaccine were assessed through questionnaires. 2023 2023
3 CoV2IP-Individuals-Year4 Impact of medium- and long-term side effects of SARS-CoV-2 vaccine were assessed through questionnaires. 2024 2024

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Family and household structure
Education
Ethnicity, race and religion
Labour force and retirement

Lifestyle and behaviours

Tobacco
Leisure activities

Perception of health, quality of life, development and functional limitations

Perception of health

Diseases

Certain infectious and parasitic diseases (A00-B99)
Diseases of the respiratory system (J00-J99)
Diseases without precise specification or falling into multiple categories

Symptoms and signs

Symptoms related to multiple categories

Medication and supplements

Medication and supplement intake

Non-pharmacological interventions

Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Hospitalizations

Physical measures and assessments

Anthropometry

Laboratory measures

Virology

Preschool, school and work life

Work life

Physical environment

Housing characteristics

Administrative information

Identifiers
Date and time-related information